SynderBio Inc.

Medtech · Private

A point-of-care device that enriches malignant cells from urine specimens using high-level fluid shear stress to improve bladder cancer detection accuracy.

synderbio.com →
Grants
$1.0M
5 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
2
1 granted · 1 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grant· 1 of 2 same dayDepartment of Health and Human Services · Phase I · Improved preparation of cell suspensions for single cell genomics$218,782
Federal grant· 2 of 2 same dayDepartment of Health and Human Services · Phase I · Improved preparation of cell suspensions for single cell genomics$218,782
Federal grant· 1 of 2 same dayDepartment of Health and Human Services · Phase I · Improved detection of bladder cancer recurrence using a biophysical biomarker$299,860
Federal grant· 2 of 2 same dayDepartment of Health and Human Services · Phase I · Improved detection of bladder cancer recurrence using a biophysical biomarker$301,860
Federal grantDepartment of Health and Human Services · Phase I · Improved detection of bladder cancer recurrence using a biophysical biomarker$2,000
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1781NEUROTECHR3 INC.——
1782LEVATE LLC——
1783Arnoldware Applications LLC——
1784SynderBio Inc.——
1785TYMORA ANALYTICAL OPERATIONS LLC——
1786COLDSTEEL LASER, INC——
1787LA JOLLA ALCOHOL RESEARCH INC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 1 granted of 2

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.